Published in Drug Week, April 15th, 2011
"Review of the patients who underwent intravenous CSA for ulcerative colitis between 1989 and 2003. A total of 71 patients with severe ulcerative colitis were treated with IV CSA. The median length of follow-up was 1.5 years (mean = 3 y) (range 1 mo to 14 y) (IQR 0.6 to 4.6)....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.